|
DDHD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.063600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.000400E-01 |
| Normal-vs-Stage2 |
4.370400E-01 |
| Normal-vs-Stage3 |
1.425570E-01 |
| Normal-vs-Stage4 |
4.955600E-02 |
| Stage1-vs-Stage2 |
6.959400E-01 |
| Stage1-vs-Stage3 |
2.352200E-01 |
| Stage1-vs-Stage4 |
1.692180E-01 |
| Stage2-vs-Stage3 |
5.665400E-01 |
| Stage2-vs-Stage4 |
2.744400E-01 |
| Stage3-vs-Stage4 |
5.664000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.459800E-01 |
| Normal-vs-AfricanAmerican |
2.682400E-01 |
| Normal-vs-Asian |
8.397000E-03 |
| Caucasian-vs-AfricanAmerican |
2.803800E-01 |
| Caucasian-vs-Asian |
8.070000E-02 |
| AfricanAmerican-vs-Asian |
4.254200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.789400E-01 |
| Normal-vs-Female |
9.871200E-01 |
| Male-vs-Female |
3.334000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.060360E-01 |
| Normal-vs-Extreme_Weight |
4.162800E-01 |
| Normal-vs-Obese |
7.699800E-01 |
| Normal-vs-Extreme_Obese |
2.425200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.815600E-01 |
| Normal_Weight-vs-Obese |
1.598820E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.763800E-01 |
| Extreme_Weight-vs-Obese |
6.089200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.170000E-01 |
| Obese-vs-Extreme_Obese |
4.027000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.527600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.822600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.251800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.428430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.949000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.504000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.040000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.844200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.688790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.815200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.747400E-01 |
| Normal-VS-Type2 PRCC |
2.538000E-02 |
| Normal-VS-KIRP CIMP |
1.407420E-01 |
| Normal-VS-Unclassified PRCC |
4.867400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.495200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.575200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.975600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.822600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.388100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.722990E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.036380E-02 |
| Normal-vs-N1 |
8.430600E-01 |
| Normal-vs-N2 |
4.138200E-01 |
| N0-vs-N1 |
2.915800E-01 |
| N0-vs-N2 |
7.701000E-01 |
| N1-vs-N2 |
7.539200E-01 |
|
|
